Nutex Health (NASDAQ:NUTX) Trading Down 7% – Here’s Why

Shares of Nutex Health Inc. (NASDAQ:NUTXGet Free Report) were down 7% during mid-day trading on Wednesday . The company traded as low as $174.00 and last traded at $174.7370. 34,873 shares traded hands during mid-day trading, a decline of 80% from the average session volume of 178,596 shares. The stock had previously closed at $187.90.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. B. Riley Financial started coverage on Nutex Health in a research report on Friday, June 26th. They set a “buy” rating and a $290.00 price target on the stock. Weiss Ratings upgraded shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. Zacks Research raised shares of Nutex Health to a “hold” rating in a research report on Monday, June 29th. Lake Street Capital initiated coverage on shares of Nutex Health in a report on Tuesday, June 2nd. They set a “buy” rating and a $235.00 target price for the company. Finally, Wall Street Zen raised shares of Nutex Health from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, Nutex Health has a consensus rating of “Moderate Buy” and a consensus target price of $243.33.

View Our Latest Stock Report on NUTX

Nutex Health Stock Performance

The stock’s 50-day moving average price is $143.08 and its 200-day moving average price is $130.70. The company has a market cap of $1.26 billion, a P/E ratio of 14.23 and a beta of 0.21. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.14 and a quick ratio of 3.12.

Nutex Health (NASDAQ:NUTXGet Free Report) last released its quarterly earnings results on Thursday, April 30th. The company reported $6.52 EPS for the quarter, topping analysts’ consensus estimates of $3.99 by $2.53. Nutex Health had a net margin of 10.95% and a return on equity of 23.50%. The business had revenue of $216.49 million for the quarter, compared to analyst estimates of $227.80 million. Equities analysts anticipate that Nutex Health Inc. will post 22.72 EPS for the current year.

Institutional Trading of Nutex Health

Large investors have recently modified their holdings of the stock. Islay Capital Management LLC bought a new position in Nutex Health in the 4th quarter valued at about $34,000. BNP Paribas Financial Markets grew its position in Nutex Health by 966.7% during the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock worth $40,000 after acquiring an additional 290 shares during the last quarter. Royal Bank of Canada grew its position in Nutex Health by 752.4% during the 4th quarter. Royal Bank of Canada now owns 358 shares of the company’s stock worth $59,000 after acquiring an additional 316 shares during the last quarter. Osaic Holdings Inc. increased its stake in Nutex Health by 280.3% in the 4th quarter. Osaic Holdings Inc. now owns 810 shares of the company’s stock worth $133,000 after purchasing an additional 597 shares during the period. Finally, EverSource Wealth Advisors LLC purchased a new stake in shares of Nutex Health during the first quarter valued at approximately $83,000. 5.32% of the stock is owned by institutional investors and hedge funds.

About Nutex Health

(Get Free Report)

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.

See Also

Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.